Futura Medical (GB:FUM) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Futura Medical PLC has successfully passed all resolutions at its Annual General Meeting, with shareholders expressing strong support for the company’s direction. The resolutions included the reappointment of directors, auditors, and the authorization for the company to allot shares and disapply pre-emption rights. The consumer healthcare company is known for its innovative sexual health products, such as Eroxon®, a fast-acting gel for Erectile Dysfunction that’s gaining traction globally.
For further insights into GB:FUM stock, check out TipRanks’ Stock Analysis page.
